Selank
Selank
Also known as: TP-7, Selanc
Overview
Key Facts
Primary Goal: Research and therapeutic applications of Selank
Modulates GABAergic neurotransmission, enhancing inhibitory signaling without direct GABA-A receptor binding. Influences expression of BDNF and serotonin transporter genes.
Dosing Information
~several minutes (active metabolites persist 3-5 hours)
150–500 mcg
1-3 times daily
14-30 days
Benefits
- Anxiolytic effects comparable to benzodiazepines without sedation or dependence
- Enhanced memory consolidation and learning
- Immunomodulatory activity via tuftsin backbone
- Improved emotional stability and stress resilience
- Increased IL-6 expression and immune system regulation
Side Effects
Mechanism of Action
Modulates GABAergic neurotransmission, enhancing inhibitory signaling without direct GABA-A receptor binding
Influences expression of BDNF and serotonin transporter genes
Tuftsin backbone activates phagocytic immune cells and modulates cytokine expression
Stabilizes enkephalin degradation, indirectly enhancing endogenous opioid tone
Contraindications
Do not use this peptide if any of the following apply:
- Pregnancy or breastfeeding
- Active autoimmune conditions (due to immunomodulatory effects)
- Known hypersensitivity to tuftsin-derived compounds
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Selank was approved in Russia in 2009 for generalized anxiety disorder and as a nootropic. Clinical studies demonstrated anxiolytic efficacy comparable to medazepam (a benzodiazepine) without sedation, cognitive impairment, or withdrawal symptoms. Research has confirmed its influence on over 50 genes related to GABAergic signaling, serotonin transport, and immune function. Its dual anxiolytic-immunomodulatory profile is unique among peptide-based compounds.
Frequently Asked Questions
Common questions about Selank
UK-Specific Information
Exclusive data points and guidance for UK residents using Selank
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok